PIC provides the first investment received by Inaedis, a Princeton University spin-out.
PRINCETON, NEW JERSEY (January 8, 2024) — Inaedis, Inc., a new platform biotechnology company, received its first ever investment from the Princeton Innovation Center.
Prior to receiving the investment, Inaedis founder and CEO Dr. Maksim Mezhericher was part of the inaugural class of START Entrepreneurs, Princeton’s 12-month academic fellowship and startup accelerator. During the fellowship, Dr. Mezhericher developed and tested a new, scalable system to implement Inaedis’s proprietary room-temperature dehydration (RTAD) technology. The innovative technology can be incorporated into existing pharmaceutical development laboratories or into the supply chain between a manufacturer and a distribution hub.
The Princeton Innovation Center’s follow-on investment from START provides ongoing lab and co-working space for Inaedis, as well as legal and intellectual property support. Dr. Mezhericher is continuing to refine the technology and attract additional partnerships and investment.
“We’re grateful to the Princeton Innovation Center for the investment and providing Inaedis its first home at the Princeton Innovation Center Biolabs,” said Dr. Mezhericher. “With this investment, we’re working shoulder-to-shoulder with other startups to build the next generation of companies that will solve hard problems using biotechnology.”
Inaedis, Inc.
Inaedis, Inc. is a spin-out company from Princeton University developing a pharmaceutical platform changing the future of drug development, delivery, and distribution by powderizing life-saving vaccines and biologics.
First developed by Princeton scientists during the Covid-19 pandemic, our goal is to give everyone access to the miracles of modern medicine. Our proprietary Rapid Room-Temperature Dehydration (RTAD) platform technology finally solves the global dilemma posed by the thermal stabilization requirements of life-saving heat and freeze-sensitive vaccines and biologics.
Inaedis is led by its founders: CEO Dr. Maksim Mezhericher and Prof. Howard A. Stone and is backed by Roadrunner Venture Studios and Princeton Innovation Center.
Media Contact: Maksim Mezhericher, maksim@inaedis.com